BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. The company was incorporated in 1991 and is headquartered in Oulu, Finland.
Frequently asked questions
What sector does BBS-Bioactive Bone Substitutes Oyj (BONEH) operate in?
BBS-Bioactive Bone Substitutes Oyj belongs to the Healthcare sector and operates in the Medical Devices industry.
What is BBS-Bioactive Bone Substitutes Oyj (BONEH) current stock price?
As of the latest data, BBS-Bioactive Bone Substitutes Oyj stock price is €0.05, with a previous close of €0.05.
What is BBS-Bioactive Bone Substitutes Oyj (BONEH) current market capitalization?
BBS-Bioactive Bone Substitutes Oyj market cap is approximately 1.50 million.
What is BBS-Bioactive Bone Substitutes Oyj (BONEH) Earnings Per Share (EPS)?
The trailing EPS is -€0.15, and the forward EPS is -€0.11.
Does BBS-Bioactive Bone Substitutes Oyj (BONEH) pay dividends?
No. BBS-Bioactive Bone Substitutes Oyj does not pay a dividend.
What is BBS-Bioactive Bone Substitutes Oyj (BONEH) beta (volatility) score?
BBS-Bioactive Bone Substitutes Oyj has a beta of 0.374, indicating lower volatility than the overall market.